Such techniques can be automatically applied using implantable cardioverter defibrillators (ICDs) and offer the potential for painless termination of ventricular tachycardia (VT). Reduction in ...

The usual first treatment to prevent dangerous episodes of ventricular tachycardia is anti-arrhythmia medications. However, these medications may have serious long-term side effects, such as ...

An initial strategy of catheter ablation leads to a lower risk for a composite primary end point than antiarrhythmic drug therapy among patients with ischemic cardiomyopathy and ventricular ...

The pharmacological treatment of VF/pulseless VT is of secondary importance to early defibrillation ... Lignocaine has no effect on supraventricular tachycardia (SVT). Like most antiarrhythmic drugs, ...

LIDOCAINE (Xylocaine) has become one of the most frequently used drugs in the treatment of ventricular arrhythmias, particularly those associated with acute myocardial infarction. It has been ...

CASE DESCRIPTION: 2 spayed female (8 and 9 years old) and 1 sexually intact male (6.5 years old) Boxers were treated because of sustained ventricular tachycardia by electrical cardioversion.

The Food and Drug Administration (FDA) has approved Rapiblyk (landiolol) for the short-term reduction of ventricular rate ... with supraventricular tachycardia. Treatment with landiolol resulted ...

leading to dangerous rapid heart racing called ventricular tachycardia." John Sapp, M.D., lead author, professor of medicine and assistant dean of clinical research at Dalhousie University ...

Among patients assigned to drug therapy, adverse events attributed to antiarrhythmic drug treatment included ... can reduce the risk of recurrent ventricular tachycardia and implantable ...

In 3-year pilot trial, regional EMS agencies will try new protocol to improve the speed of treatment OHSU is leading a new ...